International Journal of Infection

Published by: Kowsar

The Prevalence of Hepatitis B and C Viruses Among Blood Donors Attending Blood Bank in Duhok, Kurdistan Region, Iraq

Nawfal Rasheed Hussein 1 , * , Sefar Mohamad Haj 1 , Lokman Amin Almizori 1 and Ali Ahmed Taha 2
Authors Information
1 Department of Internal Medicine, School of Medical Sciences, Faculty of Medicine, University of Duhok, Duhok, Iraq
2 The Department of Infection Control, General Directorate of Health-Duhok, Duhok, Iraq
Article information
  • International Journal of Infection: January 01, 2017, 4 (1); e39008
  • Published Online: August 8, 2016
  • Article Type: Research Article
  • Received: May 7, 2016
  • Accepted: May 9, 2016
  • DOI: 10.17795/iji-39008

To Cite: Rasheed Hussein N, Mohamad Haj S, Amin Almizori L, Ahmed Taha A. The Prevalence of Hepatitis B and C Viruses Among Blood Donors Attending Blood Bank in Duhok, Kurdistan Region, Iraq, Int J Infect. 2017 ; 4(1):e39008. doi: 10.17795/iji-39008.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnote
References
  • 1. Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S, Bustos JA, et al. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infect Dis. 2014; 14: 218[DOI][PubMed]
  • 2. Zaheer H, Saeed U, Waheed Y, Karimi S, Waheed U. Prevalence and trends of hepatitis B, hepatitis C and human immunodeficiency viruses among blood donors in Islamabad, Pakistan 2005-2013. J Blood Disorders Transf. 2014; 5(217): 2
  • 3. Walter SR, Thein HH, Amin J, Gidding HF, Ward K, Law MG, et al. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J Hepatol. 2011; 54(5): 879-86[DOI][PubMed]
  • 4. Andrade AF, Oliveira-Silva M, Silva SG, Motta IJ, Bonvicino CR. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Mem Inst Oswaldo Cruz. 2006; 101(6): 673-6[PubMed]
  • 5. Al Abaddi B, Al Amr M, Abasi L, Saleem A, Hazeem NA, Marafi A. Seroprevalence of HBV, HCV, HIV and syphilis infections among blood donors at Blood Bank of King Hussein Medical Center: a 3 year study. World Fam Med J Incorpor Middle East J Fam Med. 2014; 12(6): 10-3
  • 6. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz. 2005; 100(1): 13-6[PubMed]
  • 7. Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One. 2014; 9(4)[DOI][PubMed]
  • 8. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA. 2000; 284(2): 229-35[PubMed]
  • 9. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49(10): 2214-20[DOI][PubMed]
  • 10. Dodd RY, Notari E, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002; 42(8): 975-9[PubMed]
  • 11. Lavanya V, Viswanathan T, Malar SAS, Malarvizhi A, Moorthy K. Prevalence of hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Int J Med Med Sci. 2012; 4(6): 128-37
  • 12. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006; 21(4): 299-305[DOI][PubMed]
  • 13. Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999; 341(12): 866-70[DOI][PubMed]
  • 14. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005; 54: 1-31[PubMed]
  • 15. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009; 27(47): 6550-7[DOI][PubMed]
  • 16. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009; 200(1): 39-47[DOI][PubMed]
  • 17. Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis. 2012; 16(2)-8[DOI][PubMed]
  • 18. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006; 28: 112-25[DOI][PubMed]
  • 19. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997; 336(26): 1855-9[DOI][PubMed]
  • 20. Hussein NR. Prevalence of HBV, HCV and HIV and Anti-HBs antibodies positivity in healthcare workers in departments of surgery in Duhok City, Kurdistan Region, Iraq. Int J Pure Appl Sci Technol. 2015; 26(2): 70
  • 21. Hussein NR, Rasheed ZA, Taha AA, Shaikhow SK. The Prevalence of Hepatitis D Virus Infection amongst Patients with Chronic Active Hepatitis B Virus Infection in Duhok Governorate. Int J Pure Appl Sci Technol. 2015; 28(1): 1
  • 22. Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol. 2016; 3(1)[DOI][PubMed]
  • 23. Mahmood AK, Addose SA, Salih HA, Khadi AA. Seroprevalence of HBs ag and Anti HCV positive blood donors in Najaf governorate. Iraqi J Community Med. 2001; 14: 29-33
  • 24. Awadalla HI, Ragab MH, Osman MA, Nassar NA. Risk factors of viral hepatitis B among Egyptian blood donors. Br J Med Med Res. 2011; 1(1): 7
  • 25. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005; 45(12): 1973-80[DOI][PubMed]
  • 26. Mohammed Abdullah S. Prevalence of hepatitis B and C in donated blood from the jazan region of saudi arabia. Malays J Med Sci. 2013; 20(2): 41-6[PubMed]
  • 27. Kafi-abad SA, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med. 2009; 19(4): 189-94[DOI][PubMed]
  • 28. Meena M, Jindal T, Hazarika A. Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study. Transfusion. 2011; 51(1): 198-202[DOI][PubMed]
  • 29. Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis. 2012; 55 Suppl 1-9[DOI][PubMed]
  • 30. Vriend HJ, Van Veen MG, Prins M, Urbanus AT, Boot HJ, Op De Coul EL. Hepatitis C virus prevalence in The Netherlands: migrants account for most infections. Epidemiol Infect. 2013; 141(6): 1310-7[DOI][PubMed]
  • 31. Khodabandehloo M, Roshani D, Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. J Res Med Sci. 2013; 18(8): 674-82[PubMed]
  • 32. Akselrod H, Grau LE, Barbour R, Heimer R. Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population. Am J Public Health. 2014; 104(9): 1713-21[DOI][PubMed]
  • 33. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 2010; 14(11)-40[DOI][PubMed]
  • 34. Corona R, Prignano G, Mele A, Gentili G, Caprilli F, Franco E, et al. Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1. Epidemiol Infect. 1991; 107(3): 667-72[PubMed]
  • 35. Toussi SS, Abadi J, Rosenberg M, Levanon D. Prevalence of hepatitis B and C virus infections in children infected with HIV. Clin Infect Dis. 2007; 45(6): 795-8[DOI][PubMed]
  • 36. Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012; 55 Suppl 1-5[DOI][PubMed]
  • 37. Singhal V, Bora D, Singh S. Hepatitis B in health care workers: Indian scenario. J Lab Physicians. 2009; 1(2): 41-8[DOI][PubMed]
  • 38. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004; 32(8): 493-5[DOI][PubMed]
  • 39. Omar N, Salama K, Adolf S, El-Saeed GS, Abdel Ghaffar N, Ezzat N. Major risk of blood transfusion in hemolytic anemia patients. Blood Coagul Fibrinolysis. 2011; 22(4): 280-4[DOI][PubMed]
  • 40. Parry J. At last a global response to viral hepatitis. Bull World Health Organ. 2010; 88(11): 801-2[DOI][PubMed]
  • 41. Sypsa V, Hadjipaschali E, Hatzakis A. Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol. 2001; 17(8): 721-8[PubMed]
  • 42. Asthana S, Kneteman N. Operating on a patient with hepatitis C. Can J Surg. 2009; 52(4): 337-42[PubMed]
  • 43. Redd JT, Baumbach J, Kohn W, Nainan O, Khristova M, Williams I. Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis. 2007; 195(9): 1311-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments